Abstract The present study aims at determining the structure-activity relationships (SAR's) ruling the biological function of MGBG (methylglyoxal bis(guanylhydrazone)), a competitive inhibitor of S-adenosyl-L-methionine decarboxylase displaying anticancer activity, involved in the biosynthesis of the naturally occurring polyamines spermidine and spermine. In order to properly understand its biochemical activity, MGBG's structural preferences at physiological conditions were ascertained, by quantum mechanical (DFT) calculations.
Introduction
Methylglyoxal bis(guanylhydrazone) (MGBG, Fig. 1 ) is a polycation (at physiological conditions) containing two guanidinium groups, which acts as a competitive inhibitor of S-adenosyl-L-methionine decarboxylase (SAMDC) (Wallace and Fraser 2004) , being thus involved in the biosynthesis of the biogenic polyamines spermidine and spermine. During the 1960s it garnered a considerable interest for its antineoplastic and strong cytotoxic effects (Mihich 1963) , but it was discarded from therapeutical use due to its severe toxicity. However, subsequent clinical investigations have shown that particular administration conditions strongly reduce MGBG's toxicity while preserving its antitumoural action (Von Hoff 1994) .
Although the mechanisms underlying the antiproliferative and cytotoxic effects of MGBG are still not well understood, they are probably linked to the production of reactive oxygen species upon MGBG oxidation (which, however, has not been proved), as well as to its interaction with polyamine metabolism and mitochondrial function. In fact, biogenic polyamine metabolism is one of the main targets of MGBG, which reduces the intracellular polyamine content through induction of spermidine-spermine acetyltransferase (SSAT) (involved in polyamine catabolism) (Regenass et al. 1992 ) and inhibition of SAMDC (essential for polyamine synthesis) (Williams-Ashman and Schenone 1972). Again polyamine oxidation represents a crucial catabolic pathway in polyamine metabolism by which these polycations can be involved in oxidative stress and apoptosis (Agostinelli et al. 2004) . In this regard, it has been reported that MGBG is able to inhibit polyamine oxidase activity in thymus suggesting a positive role for this drug in HIV related diseases (Ferioli and Armanni 2003) . Furthermore, some reported studies evidence an increased MGBG antitumour activity in malnourished patients, possibly due to their low intracellular polyamine pool (Von Hoff 1994) .
At the mitochondrial level, MGBG exhibits inhibition of protein phosphorylation (Gosalvez et al. 1974; Mailer and Petering 1976; Muhammed et al. 1983; Warrell and Burchenal 1983) , impairment of carnitine palmitoyl tranferase and carnitine acetyl transferase (Nikula et al. 1985; Brady et al. 1987) , and an overall damaging effect due to selective inhibition of mitochondrial DNA synthesis (Feuerstein et al. 1979) . Reported studies on Ehrlich ascites carcinoma cells suggest that the precursor of MGBG, methylglyoxal, induces cytotoxicity by inhibiting the electron flux along Complex I of the mitochondrial respiratory chain (Ray et al. 1994) . In isolated rat liver mitochondria (RLM), MGBG was found to display an inhibitory effect towards Ca 2+ -induced permeability transition in the presence of phosphate and oxalacetate (Toninello et al. 1988) , similarly to what is known to occur in the presence of spermine and spermidine (Lapidus and Sokolove 1994; Tassani et al. 1995) . In this regard, it should be emphasised that MGBG binding to the mitochondria membrane, at the site responsible for polyamine transport, must be excluded, according to the particular structural characteristics of both the receptors and MGBG Toninello et al. 1999) . This leads to the conclusion that MGBG's inhibitory effect on polyamine binding to membranes probably arises from conformational changes at the receptor, induced upon binding of the drug to a neighbouring site(s) ) (in accordance with the induced-fit theory of drug-receptor interaction). The mechanism (or mechanisms) associated to MGBG transport in mitochondria is still not known, nor that associated to its inhibition of mitochondrial permeability transition (MPT) induction.
The biochemical properties of polyamines and related compounds are recognizedly dependent on their geometrical characteristics, at the molecular level. In order to establish the relationship between the structural preferences of MGBG and its biological action-in particular its transport mechanism(s), binding to macromolecular structures and MPT prevention-a conformational analysis in aqueous solution, as a function of pH, was carried out through theoretical methods. The results obtained agree well with a previous study carried out for the biogenic amine agmatine, which also contains a guanidinium moiety, known to be essential for the activity of this kind of polyamines ). with Escherichia coli arginine decarboxylase, as reported in (Cabella et al. 2001) . Hepes, EGTA and rotenone were purchased from Sigma-Aldrich. Cyclosporin A was kindly provided by Sandoz Pharma, Basel (Switzerland). All other reagents were of the highest quality available.
Materials and methods

Chemicals
Quantum mechanical calculations
The quantum mechanical calculations-full geometry optimisation and calculation of the harmonic vibrational frequencies-were performed using the GAUSSIAN 03W program (Frisch et al. 1998) within the density functional theory (DFT) approach, in order to properly describe the electron correlation effects (particularly important in this kind of nitrogen-containing systems). The widely employed hybrid method denoted by B3LYP (Cotton and Feng 1998; Wagener and Frenking 1998) , which includes a mixture of Hartree-Foch and DFT exchange terms and the gradient-corrected correlation functional of Lee, Yang and Parr (Lee et al. 1988; Miehlich et al. 1989) , as proposed and parametrised by Becke (1988 Becke ( , 1993 , was used, along with the double-zeta split valence basis set 6-31G** (Hariharan and Pople 1973; Francl et al. 1982) . Molecular geometries were fully optimised by the Berny algorithm, using redundant internal coordinates (Peng et al. 1996) : the bond lengths to within ca. 0.1 pm and the bond angles to within ca. 0.1°. The final root-mean-square (rms) gradients were always less than 3 9 10 -4 hartree bohr -1 or hartree radian -1 . No geometrical constraints were imposed on the molecules under study.
The solvent effect (water) was simulated by performing Self-Consistent Reaction Field (SCRF) calculations, using Tomasís Polarised Continuum Model (PCM) Cammi and Tomasi 1995; Miertus et al. 1981) . This approach defines the molecular cavity as the union of a series of interlocking spheres centered on the distinct atoms of the system. A dielectric constant of 78.39 was used for water. Moreover, two water molecules were explicitly considered in the calculations, in order to account for the (N)HÁÁÁO(H) interactions between MGBG and the solvent, which are of the utmost importance for an accurate representation of this kind of systems under physiological conditions.
Harmonic frequency calculations were performed for all the lowest energy conformations, at the PCM/B3LYP/6-31G** level, in view of determining if these were real minima in the potential energy surface (conformers). Mulliken atomic charges and total dipole moments were obtained for the different MGBG conformers. The relative populations were determined according to the Boltzmann distribution (at 25 and 37°C), based on the relative conformational energies yielded by the geometry optimisation process.
Biochemical assays
Hepatocytes were prepared from male Wistar rats (weighing 150-200 g) by the collagenase perfusion method (Probst and Unthan-Fechner 1985) and cultured as reported by Cabella et al. (2001) , using M199 medium supplemented with 2 mg/ml bovine serum albumin (BSA), 3.6 mg/ml Hepes, 100 U/ml penicillin, 100 lg/ml streptomycin, 5% horse serum and 1 nmol/ml insulin. After 48 h, the medium was removed, the cells were washed once with 0.8% NaCl, 0.02% KCl, 0.115% Na 2 HPO 4 and 0.02% KH 2 PO 4 pH 7.2, and suspended in 2 ml of Earl's balanced salt solution with both labeled MGBG, or agmatine. After further incubations at different times, the medium was removed and the cells were washed three times with ice-cold NaCl/phosphate, and frozen at -80°C. MGBG and agmatine uptake were measured after solubilisation of each sample in 1 ml of 0.2 M HClO 4 and centrifuging at 50,000g for 15 min, followed by total radioactivity counting of the supernatant by liquid scintillation. Cell proteins were determined in the 1 M NaOH solubilised pellet, as described by Bradford (1976) .
RLM were isolated in 0.25 M sucrose and 5 mM Hepes (pH 7.4) by conventional differential centrifugation (Schneider and Hogeboom 1950) . Mitochondrial protein concentration was assayed by the biuret method, using BSA as a standard (Gornall et al. 1949) . Mitochondrial incubations were carried out at 20°C, with 1 mg of mitochondrial protein/ml in the following standard: medium 250 mM sucrose, 10 mM Hepes (pH 7.4), 5 mM Nasuccinate and 1.25 lM rotenone. A sucrose-based medium was chosen, in order to compare the results with those obtained in polyamine transport studies (for a review see Toninello et al. 2004 .
Mitochondrial membrane potential (DW) values were calculated on the basis of the distribution of the lipidsoluble tetraphenylphosphonium cation (TPP + ) through the inner membrane, measured on a home-made TPP + -specific electrode (Kamo et al. 1979 Results and discussion
Quantum mechanical calculations
A complete geometry optimisation was carried out for MGBG in aqueous solution, considering its different protonation states, with particular emphasis on the diprotonated form (H 2 MGBG), which is the major species under physiological conditions (pK a (MGBG) = 7.5 and 9.2; WilliamAshman and Seidenfeld 1986). Five populated conformers (at room temperature) were obtained for dicationic H 2 MGBG (Table 1) , from which only three have a population (at 37°C) higher than 1%-MGBG 21, MGBG 22 and MGBG 23 (Fig. 2) . The most stable geometry MGBG 21, largely predominant at 25°C, displays a coplanar structure and a trans orientation of the two (C=)NH groups relative to the NH 3 + moieties. Also, internal rotation around the C 1 -N 5 , C 13 -N 12 and C 9 -C 10 bonds lead to a distinct orientation of the methyl group (in C 21 ) relative to the main carbon chain of the molecule, the lowest energy geometries being those for which C 21 H 3 and the N 2 H 3 terminal are in a syn orientation-MGBG 21, MGBG 22 and MGBG 23 species. Actually, the two less stable conformers MGBG 24 and MGBG 25 differ from these only in the relative position of the CH 3 and NH 3 + groups. MGBG 24, however, displays a quite high dipole moment as compared to the other dicationic species (Table 1) , which may be responsible for an increase of its in vivo population. Similarly to reported results on the biogenic amine agmatine , which contains one NH 3 + terminal and a guanidinium moiety, a trans localisation of the two imino NH's relative to the NH 3 + groups (MGBG 21) is preferred over a cis orientation. In fact, the conformation of the guanidinium group ((C 1 =)N-H) presently obtained for the most stable MGBG geometry-trans relative to the C 1 -N 2 bond-is identical to the one previously obtained for agmatine (Fig. 3) . This is easily understandable for the N-protonated species investigated, in the light of minimisation of the H (Fig. 1) . Apart from diprotonated MGBG, the monoprotonated (HMGBG) and unprotonated (neutral) forms of the molecule were also investigated as to their conformational preferences. Figure 4 comprises the most stable structures calculated for each of these species, in aqueous solution. In fact, the monocationic geometry MGBG 11 is expected to be present at physiological conditions along with the predominant diprotonated species MGBG 21 (Fig. 3) , its relative populations (ca. 60:40%) being determined by the amine pK a values of the molecule. Moreover, the very high dipole moment of the monoprotonated conformer MGBG 11 (l = 17.2 D) can favour its occurrence at physiological conditions (polar medium).
Biological activity
The results presently reported refer to particular biological mechanisms associated to MGBG, such as its transport across the plasma and mitochondrial membranes and the prevention of the MPT process. Most probably these events involve different MGBG structures, thus evidencing the importance of their exact knowledge.
As represented in Fig. 5 , at the exogenous concentration of 50 lM MGBG is taken up by an hepatocyte culture at about 50 pmol/mg prot., for a 100 min incubation time. This uptake is completely insensitive to the presence of ouabain, while the uncoupler carbonyl cyanidep-trifluorometoxyphenylhydrazone (FCCP) exhibits an inhibition of about 50%. For comparison purposes, Fig. 5 also displays the transport of the biogenic amine agmatine. For a concentration of 50 lM, agmatine is shown to be taken up by hepatocytes at about 40 pmol/mg prot. Also in this case ouabain is ineffective, whereas FCCP induces an inhibition of about 50%. The choice of agmatine for comparison purposes is due to the structural similarity between this amine and MGBG. Figure 6 depicts the transport of MGBG, at a 1 mM exogenous concentration, in RLM energised by succinate oxidation, in the presence of rotenone (in order to favour substrate oxidation) and phosphate (to obtain a very high DW, Fig. 6, inset) . MGBG transport is compared with that of agmatine, the mechanism of which has recently been characterised Agostinelli et al. 2007) , and with that of spermidine, also previously reported (Toninello et al. 1992 ) (also for a 1 mM concentration). It is verified that MGBG is transported at about 85 nmol/mg prot, for a 20 min incubation period, a higher extent than that measured for either agmatine (&70 nmol/mg prot.) or spermidine (&45 nmol/mg prot.). In the presence of FCCP, which collapses DW (Fig. 6, inset ), all these transport processes are almost completely inhibited, demonstrating a clear mechanistic difference relative to the transport mechanism across the plasma membrane (Fig. 5) .
The decrease of about 1unit in the apparent absorbance (at 540 nm) of the mitochondrial suspension is plotted in Fig. 7 , which is indicative of mitochondrial swelling, induced by 50 lM Ca 2+ in the presence of phosphate. The total inhibition observed in the presence of the immunosuppressant cyclosporin A (CsA) demonstrates that this absorbance change is due to the opening of the transition pore, related to MPT induction (for a review see Zoratti and Szabò 1995) . If RLM are incubated with of 1 mM MGBG, mitochondrial swelling is completely Fig. 7 Inhibition of Ca 2+ -induced mitochondrial permeability transition by MGBG and carnitine. RLM were incubated in standard medium (as described in the Experimental Section), in the presence of 1 mM-Pi and 50 lM-Ca 2+ . Where indicated 1 mM-MGBG, 1 mMcarnitine or 1 lM-CsA were added (Five independent experiments yielded almost identical results) prevented (Fig. 7) , which also occurs for agmatine and spermidine for the same MGBG dosage (results available from the authors upon request). Incubation of RLM with 1 mM carnitine, in turn, results in a strong but not complete inhibition of the swelling.
The results presently obtained lead to the characterisation of the most stable physiological MGBG structures. Furthermore, this work also aims at establishing the MGBG geometry (or geometries) able to cross the plasma and mitochondrial membranes, and to interact with different macromolecular structures in vivo, leading to the known MGBG antitumoural effect.
According to the molecule's pK a values (7.5 and 9.2), both the mono-and diprotonated forms of the molecule are present under physiological pH (ca. 60:40%). Among the five diprotonated structures calculated as conformational minima for MGBG, the most stable and largely predominant one is MGBG 21, with a relative population of 95.7% and a total dipole moment of 1.3 D. However, as mentioned above, at neutral pH a significant fraction of monoprotonated form also occurs. Consequently, in the light of the theoretical data presently gathered, MGBG 21 (l = 1.3 D) and MGBG 11 (l = 17.2 D) (Figs. 3, 4) are proposed to be the main MGBG species in biological fluids and inner cell compartments of MGBG-treated patients.
A large number of reports are to be found in the literature on the MGBG transport across the plasma membrane of different cells (for a review see William-Ashman and Seidenfeld 1986), and several authors refer that MGBG shares the same transporter with biogenic polyamines. It is also possible that this drug uses the monoamine transporters EMT and OCT2, which are involved in the uptake of agmatine (Cabella et al. 2001) . Actually, since agmatine is a divalent cation at pH 7.4, comprising a guanidinium group, similarly to MGBG (Fig. 3) , this hypothesis should not be disregarded. Moreover, MGBG could be transported in the unprotonated, uncharged form, since those transporters exhibit an electroneutral behaviour (Grundemann et al. 2003) .
The results represented in Fig. 5 confirm this hypothesis. As previously demonstrated (Cabella et al. 2001) , agmatine is transported in hepatocytes by an energydependent mechanism, as ouabain, a plasma membrane deenergising agent (Clausen and Flatman 1977) proved to be an ineffective inhibitor of this process. In addition, FCCP, which collapses the electrochemical gradient of ''in situ'' mitochondria, exhibits a partial inhibition of agmatine transport, as it only excludes the entrance of the amine in the mitochondrial matrix. This data clearly shows that agmatine is transported through an electroneutral mechanism in hepatocyte cultures, supporting the statement that the unprotonated species is involved in this process as observed for EMT and OCT2 transporters (Grundemann et al. 2003 ). Figure 5 also shows that MGBG is transported in hepatocytes, even to a larger extent than agmatine, suggesting that the presence of two guanidinium groups in its molecule further favours this mechanism. The absence of the ouabain effect and the partial inhibition by FCCP confirm that MGBG is taken up in the uncharged form.
In addition, MGBG is known to cross the mitochondrial membrane: Byczkowski and coworkers (Byczkowski et al. 1981; Byczkowski and Porter 1983) reported that MGBG is taken up by RLM when incubated in energised media, while Diwan et al. (1988) observed an enhancement of MGBG transport in RLM submitted to outer membrane lysis. These observations are confirmed by the results shown in Fig. 6 , in different media, in order to establish high DW values (of about 180 mV, Fig. 6 , inset) and induce MGBG transport to a higher extent (Byczkowski et al. 1981; Byczkowski and Porter 1983; Diwan et al. 1988) . Comparison with agmatine and spermidine transport processes clearly evidences the significance of the presence of two guanidinium groups in the MGBG molecule, which leads to a larger transport extent in mitochondria relative to both agmatine (one guanidinium) and spermidine (one amino-butyl and one amino-propyl group). The decrease in spermidine transport as compared to agmatine and MGBG is due to its lower dipole moment at physiological pH (l = 2.76 D), (M. P. M. Marques, unpublished results) despite its higher charge (3+) (Toninello et al. 1992a, b) , emphasising the importance of this parameter for polycation transport in mitochondria. Recently, it was demonstrated that agmatine is carried through the mitochondrial membrane using a channel or a single-binding centre-gated pore exhibiting an electrophoretic behaviour Agostinelli et al. 2007) . Agmatine is proposed to cross the mitochondrial membrane in the monoprotonated form, due its high polarity and the significant DW at the mitochondrial surface. On the basis of these previous results for a similar polyamine, and considering the very high dipole moment of monoprotonated MGBG 11 (l = 17.2 D, even higher than that of monovalent agmatine, l = 15.8 D), it is suggested that MGBG is transported in mitochondria in the MGBG 11 conformation. Moreover, a slight amount of MGBG may also be transported as a divalent cation, in the MGBG 24 form, since this geometry has a dipole moment of 9.5 D, much higher than that of the predominant dipositive species MGBG 21 (Table 1) .
Interaction of MGBG with the macromolecules within the cell, in order to exert its biological functions, is strongly dependent on its conformational behaviour. The drug is expected to interact with the biomolecular structures by means of weak interactions-hydrogen bonds, Van der Walls forces, cation/p interactions, electrostatic closecontacts between hydrated charged groups, etc.-as verified for biogenic polyamines (Dalla Via et al. 1985 . Due to the p-resonance occurring in the guanidinium groups, MGBG has a quite rigid structure, surely not as flexible as that of spermine or even spermidine . This implies that MGBG will only bind to particular biological sites. A very important observation arose from a study on MGBG inhibition of carnitine palmitoyl transferase (Brady et al. 1987) : the guanidinium moiety was found to occupy the quaternary ammonium site of carnitine, thus suggesting that an anionic group should be located in the active site for an effective interaction with the amine to occur. Indeed, the same work reports that the MGBG chain extends with that of acylcarnitine, allowing an immino group from MGBG to occupy a position similar to the acyl carbonyl, enabling the formation of a thiolaminal with a thiol at the active site, by substituting the normal interaction of the acyl carbonyl with the SH group. This type of observations reveals a tight conformational accordance between MGBG and its biological receptors, the sites of interaction being required to display a particular architecture for the binding to be efficient. This is very surprisingly confirmed by the observation that carnitine, although with a lesser efficacy as compared to MGBG, is also able to inhibit MPT (Fig. 7 ) (see also Di Lisa et al. 1985) , suggesting that the critical binding site responsible for MPT inhibition by both MGBG and carnitine has an identical geometry to that of the active site of carnitine palmitoyl tranferase. MGBG does not easily bind to an anionic group and needs a particular receptor, with a welldefined geometry. This fact was previously discussed by William-Ashman and collaborators (1986) , who, however, ascribed it to the low electrical charge of the molecule. The present work denies this hypothesis, since it proves that MGBG occurs predominantly in a positively charged form in the physiological medium.
From the presently obtained MGBG structural data, the mono-and diprotonated species of the molecule are the ones proposed to be involved in the drug's interaction with its biological targets. Although both H 2 MGBG (MGBG 21) and HMGBG (MGBG 11) are present at physiological conditions, the requirement for charged guanidinium groups for the drug-receptor interplay to occur renders the diprotonated form the most effective.
The structural study now performed for MGBG in aqueous solution, as a function of its protonation degree, allows a thorough characterisation of the most stable geometries of the molecule at physiological conditions. Since the activity of this kind of systems (e.g. biogenic polyamines) is known to be ruled by their structural preferences, the knowledge of the conformational behaviour of MGBG is essential for the understanding of its biological role, namely its effect on enzyme activity, polyamine transport and MPT induction. As to the latter, the opening of the transition pore is proposed to be strictly related to programmed cell death and, consequently to all pathological processes linked to apoptosis.
